A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
Details
Age
Adult
Type of Study
Treatment
Locations
Outpatient CTRC
Principal Investigator
Thomas Ragole, MD
Study ID
Protocol Number: 22-2391
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers